W. John Withnall
AstraZeneca (United Kingdom)(GB)Loughborough University(GB)
Publications by Year
Research Areas
Protein Kinase Regulation and GTPase Signaling, Peptidase Inhibition and Analysis, Signaling Pathways in Disease, Pharmacogenetics and Drug Metabolism, Cellular transport and secretion
Most-Cited Works
- → Design and Synthesis of a Novel and Potent Series of Inhibitors of Cytosolic Phospholipase A2 Based on a 1,3-Disubstituted Propan-2-one Skeleton(2002)84 cited
- → Synthesis and evaluation of substrate-mimicking cytosolic phospholipase A2 inhibitors––reducing the lipophilicity of the arachidonyl chain isostere(2004)14 cited
- → Design of novel and potent cPLA2α inhibitors containing an α-methyl-2-ketothiazole as a metabolically stable serine trap(2011)7 cited
- → Synthetic FKBP12 ligands. Design and synthesis of pyranose replacements.(1994)5 cited